Alabama Therapeutics CRS [clinicaltrials_resource:e751e86cefd859eb6006fd8cf32e6423]
A Phase II Double-Blind Study of Two Doses of SC-49483 in Combination With Zidovudine (ZDV) Versus ZDV [clinicaltrials:NCT00000791]Virologic Responses To New Nucleoside Regimens After Prolonged ZDV or ddI Monotherapy [clinicaltrials:NCT00000831]Antiviral Activity of and Resistance to Lamivudine in Combination With Zidovudine, Stavudine, or Didanosine [clinicaltrials:NCT00000838]
location [clinicaltrials_vocabulary:location]
Alabama Therapeutics CRS [clinicaltrials_resource:e751e86cefd859eb6006fd8cf32e6423]
Bio2RDF identifier
e751e86cefd859eb6006fd8cf32e6423
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:e751e86cefd859eb6006fd8cf32e6423
address [clinicaltrials_vocabulary:address]
identifier
clinicaltrials_resource:e751e86cefd859eb6006fd8cf32e6423
title
Alabama Therapeutics CRS
@en
type
label
Alabama Therapeutics CRS [clinicaltrials_resource:e751e86cefd859eb6006fd8cf32e6423]
@en